Russell Cohen, MD, Discusses Medication Adherence in Inflammatory Bowel Disease
Russell Cohen, MD, says medication adherence is an important issue for inflammatory bowel disease (IBD), because patients must stay on medications long term. Dr Cohen comments, "IBD is a chronic relapsing condition, you don't just stop your medicines." There have been many breakthroughs in medication adherence for managing IBD. For instance, Dr Cohen says once-a-day dosing ensures patients don't fall behind in taking their prescribed medications.
This video was taken on May 2, 2013, at the NAMCP Spring Managed Care Forum in Orlando, FL.
Vermont Senator Bernie Sanders has introduced a bill that would require generic drugmakers to pay rebates to the federal Medicare and Medicaid programs when prices of their medications outpace inflation.
A new study shows only a small share of patients with private insurance who were newly diagnosed with diabetes in 2011-2012 enrolled in self-management training, raising questions about how well managed care could address both long-term health and cost control for this important group. These patients are a target for special attention under the ACA.
Results presented today at the American College of Rheumatology in Boston show that a 12-biomarker test did a better job of predicting radiographic progression in patients with RA. The study demonstrates how biomarkers are becoming important in managed care outside of cancer treatment.